The Effect of the Art-based Mandala Intervention on the Quality of Life of Cancer Patients Receiving Chemotherapy
NCT ID: NCT05344820
Last Updated: 2022-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2022-05-19
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mandala Painting During Chemotherapy
NCT07269340
The Effect of Mandala on Nausea, Vomiting, Pain and Anxiety in Chemotherapy Patients
NCT06508632
The Effect of Mandala Technique on Acute Nausea-vomiting and Comfort Level in Cancer Patients
NCT05885126
The Effect of Mandala on Anxiety, Physiological Parameters and Patient Satisfaction in Women With Breast Cancer
NCT06735456
The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
NCT07203742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to determine the effect of mandala application on fatigue, quality of life, rumination and alexithymia in cancer patients receiving chemotherapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mandala Intervention
To the experimental group; Mandala practice will be done for 2 hours, once a week for 8 weeks.
Art based mandala
To the experimental group; Mandala practice will be done for 2 hours, once a week for 8 weeks.
Control
No intervention will be applied to the control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Art based mandala
To the experimental group; Mandala practice will be done for 2 hours, once a week for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Conscious and no communication problems
* Being literate
* Having a cancer diagnosis
* Receiving chemotherapy treatment (planned to continue treatment for 8 more weeks)
* Willing to participate in our study voluntarily
Exclusion Criteria
* Desire to leave the study at any time
* Deterioration of compliance with the working criteria during the time of the study,
* Those who do not participate in up to four mandala applications during the study period
* Those who cannot use a pen
* Those with a diagnosis of psychiatric and neurological disease
* Patients who are scheduled for drug intervention, radiotherapy, surgery other than chemotherapy within 8 weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Yıldırım Ayaz
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif Yıldırım Ayaz, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sultan Abdülhamid Training And Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sultan Abdülhamid Training and Research Hospital
Üsküdar, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARQULA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.